Alnylam Pharmaceuticals, Inc. (ALNY) quarterly balance sheet — complete assets, liabilities & equity history
Alnylam Pharmaceuticals, Inc. (ALNY) balance sheet — 24-year assets, liabilities & shareholders' equity history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Total Current Assets | 4.62B | 4.22B | 4.05B | 3.95B | 3.64B | 3.27B | 3.3B | 3.36B | 3.17B | 2.99B | 2.98B | 2.99B | 2.52B | 2.54B | 2.69B | 2.69B | 2.47B | 2.59B | 2.81B | 2.68B |
| Cash & Short-Term Investments | 3.31B | 3.01B | 2.91B | 2.72B | 2.86B | 2.63B | 2.69B | 2.78B | 2.62B | 2.37B | 2.44B | 2.41B | 2.06B | 2.07B | 2.19B | 2.27B | 2.11B | 2.24B | 2.44B | 2.33B |
| Cash Only | 1.71B | 1.71B | 1.66B | 1.49B | 1.11B | 1.02B | 966.43M | 1.1B | 968.49M | 681.88M | 812.69M | 1.03B | 657.8M | 672.25M | 866.39M | 1.07B | 575.56M | 534.08M | 819.98M | 1.09B |
| Short-Term Investments | 1.6B | 1.3B | 1.25B | 1.23B | 1.74B | 1.61B | 1.73B | 1.68B | 1.66B | 1.69B | 1.63B | 1.37B | 1.4B | 1.4B | 1.33B | 1.19B | 1.54B | 1.71B | 1.62B | 1.23B |
| Accounts Receivable | 912.74M | 883.96M | 777.57M | 964.77M | 567.11M | 418.04M | 405.31M | 353.85M | 309.48M | 321.38M | 327.79M | 325.44M | 220.63M | 219.43M | 237.96M | 184.51M | 142.27M | 156.53M | 198.57M | 141.06M |
| Days Sales Outstanding | 63.33 | 64.06 | 73.06 | 56.42 | 57.94 | 62.35 | 58.87 | 60.91 | 43.5 | 59.75 | 68.34 | 33.47 | 62.82 | 64.46 | 58.01 | 56.87 | 60.47 | 74.93 | 60.43 | 193.1 |
| Inventory | 97.11M | 84.03M | 82.72M | 75.38M | 71.69M | 65.58M | 78.51M | 75.99M | 83.98M | 93.99M | 89.15M | 95.77M | 100.45M | 131.88M | 128.96M | 115.49M | 88.98M | 78.52M | 86.36M | 97.9M |
| Days Inventory Outstanding | 27.63 | 35.54 | 27.16 | 34.3 | 43.69 | 91.27 | 69.12 | 85.66 | 117.92 | 126.3 | 99.07 | 107.06 | 123.83 | 213.92 | 219.34 | 228.75 | 186.75 | 208.26 | 225.04 | 256.68 |
| Other Current Assets | 302.18M | 242.1M | 281.89M | 188.04M | 147.31M | 152.42M | 116.96M | 145.35M | 154.75M | 201.96M | 126.38M | 157.96M | 145.45M | 119.03M | 132.92M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 938.6M | 910.24M | 915.67M | 898.85M | 922.32M | 945.55M | 944.7M | 849.62M | 836.78M | 835.78M | 847.18M | 853.62M | 878.35M | 850.92M | 854.11M | 844.41M | 858.78M | 843.87M | 834.73M | 796.95M |
| Property, Plant & Equipment | 737.5M | 707.56M | 708.06M | 693.14M | 692.19M | 695.92M | 693.93M | 703.4M | 715.46M | 718.93M | 725.79M | 729.08M | 736.27M | 738.08M | 738.63M | 733.62M | 732.12M | 733.16M | 733.63M | 720.79M |
| Fixed Asset Turnover | 1.79x | 1.65x | 1.57x | 1.80x | 1.11x | 0.86x | 0.85x | 0.71x | 0.92x | 0.68x | 0.60x | 1.02x | 0.43x | 0.43x | 0.46x | 0.36x | 0.31x | 0.29x | 0.36x | 0.26x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 53.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 87.3M | 85.72M | 81.63M | 53.28M | 125.77M | 142.41M | 133.9M | 146.21M | 121.32M | 116.85M | 111.29M | 124.55M | 142.07M | 112.84M | 115.48M | 110.78M | 126.66M | 110.71M | 101.09M | 76.16M |
| Total Assets | 5.56B | 5.13B | 4.97B | 4.85B | 4.57B | 4.21B | 4.24B | 4.21B | 4.01B | 3.82B | 3.83B | 3.84B | 3.4B | 3.39B | 3.55B | 3.54B | 3.33B | 3.43B | 3.64B | 3.47B |
| Asset Turnover | 0.24x | 0.23x | 0.22x | 0.27x | 0.18x | 0.14x | 0.14x | 0.12x | 0.17x | 0.13x | 0.11x | 0.21x | 0.09x | 0.09x | 0.09x | 0.08x | 0.07x | 0.06x | 0.07x | 0.05x |
| Asset Growth % | 21.74% | 21.73% | 17.13% | 15.38% | 13.88% | 10.18% | 10.71% | 9.53% | 17.85% | 12.75% | 7.99% | 8.59% | 2.16% | -1.21% | -2.66% | 1.81% | -5.1% | 5.48% | 6.93% | 4.99% |
| Total Current Liabilities | 1.51B | 1.35B | 1.47B | 1.56B | 1.3B | 1.08B | 1.19B | 1.22B | 1.06B | 941.71M | 967.79M | 949.78M | 788.64M | 673.39M | 767.91M | 772.79M | 657.68M | 605.96M | 695.71M | 610.66M |
| Accounts Payable | 108.02M | 126.63M | 115.72M | 117.59M | 102.39M | 97.4M | 88.42M | 70.81M | 73.98M | 78.15M | 55.52M | 73.84M | 59.75M | 62.24M | 98.09M | 40.57M | 52.42M | 54.92M | 73.43M | 40.05M |
| Days Payables Outstanding | 35.8 | 51.66 | 40.09 | 51.31 | 63.59 | 117.7 | 71.23 | 77.53 | 100.8 | 92.18 | 69.31 | 72.89 | 65.01 | 131.49 | 124.42 | 104.04 | 119.67 | 162.11 | 138.59 | 131.15 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 97.52M | 81.79M | 113.02M | 90.52M | 61.96M | 46.17M | 54.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 4.01M | 3.21M | 4.84M | 2.54M | 15.08M | 28.16M | 55.48M | 71.03M | 69.01M | 76.85M | 102.75M | 77.14M | 54.64M | 35.79M | 42.1M | 144.21M | 114.29M | 131.84M | 149.48M | 115.04M |
| Other Current Liabilities | 258.57M | 227.49M | 477.26M | 236.94M | 120.79M | 118.09M | 214.4M | 0 | 0 | 0 | 122.17M | 44.2M | 33.65M | 23.71M | 170.98M | 35.85M | 28.5M | 21.98M | 130.66M | 26.38M |
| Current Ratio | 3.05x | 3.13x | 2.76x | 2.54x | 2.80x | 3.04x | 2.78x | 2.75x | 3.01x | 3.17x | 3.08x | 3.14x | 3.20x | 3.77x | 3.51x | 3.48x | 3.76x | 4.27x | 4.04x | 4.38x |
| Quick Ratio | 2.99x | 3.06x | 2.71x | 2.49x | 2.75x | 2.98x | 2.71x | 2.69x | 2.93x | 3.07x | 2.99x | 3.04x | 3.07x | 3.58x | 3.34x | 3.33x | 3.62x | 4.14x | 3.91x | 4.22x |
| Cash Conversion Cycle | 55.16 | 47.94 | 60.14 | 39.41 | 38.04 | 35.93 | 56.76 | 69.04 | 60.62 | 93.87 | 98.1 | 67.65 | 121.63 | 146.9 | 152.92 | 181.59 | 127.55 | 121.08 | 146.88 | 318.62 |
| Total Non-Current Liabilities | 2.69B | 2.7B | 2.71B | 3.06B | 3.01B | 3.02B | 2.99B | 2.95B | 2.96B | 3.1B | 3.08B | 3.06B | 3.02B | 2.98B | 2.94B | 2.83B | 2.5B | 2.43B | 2.36B | 2.11B |
| Long-Term Debt | 1.01B | 1.01B | 1.01B | 1.04B | 2.37B | 2.36B | 2.36B | 2.36B | 2.37B | 2.36B | 2.34B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 677.72M | 676.71M | 675.7M | 433.8M |
| Capital Lease Obligations | 210.5M | 218.03M | 225.09M | 223.42M | 224.44M | 230.06M | 229.54M | 236.03M | 239.35M | 237.83M | 243.1M | 247.71M | 253.42M | 259.4M | 261.34M | 266.32M | 272.02M | 277.39M | 281.35M | 286.03M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.47B | 1.48B | 1.48B | 1.8B | 418.47M | 428.3M | 398.11M | 358.49M | 350.43M | 319.99M | 308.44M | 1.59B | 1.56B | 1.51B | 1.46B | 1.41B | 1.37B | 1.31B | 1.25B | 1.21B |
| Total Liabilities | 4.2B | 4.05B | 4.18B | 4.62B | 4.32B | 4.1B | 4.17B | 4.17B | 4.01B | 4.04B | 4.05B | 4B | 3.81B | 3.65B | 3.7B | 3.6B | 3.15B | 3.03B | 3.06B | 2.72B |
| Total Debt | 1.27B | 1.27B | 1.28B | 1.31B | 2.74B | 2.72B | 2.74B | 2.73B | 2.71B | 2.68B | 2.68B | 1.31B | 1.31B | 1.32B | 1.32B | 1.32B | 990.98M | 995.39M | 997.59M | 760.44M |
| Net Debt | -440.91M | -437.72M | -378.86M | -181.8M | 1.63B | 1.7B | 1.78B | 1.63B | 1.74B | 2B | 1.87B | 276.01M | 656.53M | 648.1M | 453.85M | 250.65M | 415.42M | 461.31M | 177.62M | -333.55M |
| Debt / Equity | 0.94x | 1.18x | 1.62x | 5.59x | 10.93x | 23.58x | 40.89x | 84.26x | - | - | - | - | - | - | - | - | 5.63x | 2.48x | 1.70x | 1.01x |
| Debt / EBITDA | 5.17x | 4.51x | 8.80x | 3.43x | - | 83.81x | - | - | 42.57x | - | - | 5.76x | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -1.80x | -1.55x | -2.61x | -0.48x | - | 52.42x | - | - | 27.35x | - | - | 1.21x | - | - | - | - | - | - | - | - |
| Interest Coverage | 2.82x | 4.20x | 2.25x | 6.38x | 0.12x | -0.08x | -3.98x | -2.16x | 0.66x | -0.80x | -3.39x | 5.88x | -8.13x | -4.95x | -5.92x | -8.88x | -5.45x | -4.65x | -6.07x | -4.07x |
| Total Equity | 1.35B | 1.08B | 789.18M | 233.89M | 250.59M | 115.44M | 67.09M | 32.35M | -3.07M | -219.27M | -220.64M | -165.87M | -408.13M | -259.24M | -158.22M | -67.64M | 176.04M | 401.17M | 588.2M | 755.89M |
| Equity Growth % | 440.37% | 831.59% | 1076.33% | 622.92% | 8270.56% | 152.64% | 130.41% | 119.51% | 99.25% | 15.42% | -39.45% | -145.23% | -331.84% | -164.62% | -126.9% | -108.95% | -79.37% | -56.69% | -42.12% | -37.79% |
| Book Value per Share | 9.79 | 7.78 | 5.79 | 1.70 | 1.93 | 0.89 | 0.52 | 0.25 | -0.02 | -1.74 | -1.76 | -1.26 | -3.27 | -2.09 | -1.28 | -0.55 | 1.46 | 3.33 | 4.91 | 6.34 |
| Total Shareholders' Equity | 1.35B | 1.08B | 789.18M | 233.89M | 250.59M | 115.44M | 67.09M | 32.35M | -3.07M | -219.27M | -220.64M | -165.87M | -408.13M | -259.24M | -158.22M | -67.64M | 176.04M | 401.17M | 588.2M | 755.89M |
| Common Stock | 1.34M | 1.33M | 1.32M | 1.32M | 1.31M | 1.3M | 1.29M | 1.29M | 1.28M | 1.26M | 1.26M | 1.25M | 1.25M | 1.24M | 1.24M | 1.23M | 1.21M | 1.21M | 1.2M | 1.2M |
| Retained Earnings | -6.33B | -6.5B | -6.7B | -7.16B | -7.41B | -7.35B | -7.29B | -7.2B | -7.09B | -7.08B | -7.01B | -6.87B | -7.02B | -6.74B | -6.57B | -6.36B | -5.96B | -5.68B | -5.44B | -5.18B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -32.14M | -24.89M | -20.1M | -21.77M | -29.95M | -37.52M | -34.52M | -24.83M | -34.64M | -26.99M | -23.38M | -32.34M | -37.08M | -39.12M | -44.65M | -43.78M | -42.22M | -38.06M | -33.26M | -34.23M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |